BIOXNasdaqAgricultural ChemicalsUS GAAP · USD

Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp. develops and commercializes agricultural productivity solutions designed to improve crop resilience and soil health. Its business combines patented seed technologies, microbial ag-inputs, and crop nutrition and protection products, with operations and commercial reach centered in Latin America and international markets.

Revenue285m USD
Operating profit (EBIT)-28.4m USD
EBIT margin-10.0%
Net income-240m USD
Free cash flow72.2m USD

Fiscal year 2025 · change from previous year

Development 2025–2025

-1000100200300m USD2025: 285 m USD2025: EBIT -28 m USD2025285-28
RevenueOperating profit (EBIT)

Business

Share of revenue
Seed technologies30 %

Proprietary seed traits and seed-applied technologies that improve crop performance and resilience.

Microbial ag-inputs25 %

Biological inputs such as inoculants and other microbial solutions used to support plant growth.

Crop nutrition20 %

Fertilizer- and nutrient-oriented products that support crop yield and soil management.

Crop protection15 %

Products used to protect crops from pests, diseases, and stress conditions.

Other agricultural solutions10 %

Additional sustainability-oriented and productivity solutions sold through the platform.

Customers

The company sells to farmers and agricultural producers that need higher-yielding, more resilient crops and input efficiency. It also serves distributors, channel partners, and other stakeholders in the agri-input value chain that commercialize or support these products. Demand is tied to planting cycles, agronomic conditions, and the adoption of technologies that improve productivity under climate stress.

Farmers and growers

Buy seeds, microbial inputs, and crop nutrition/protection products to improve yield and resilience.

Distributors and dealers

Purchase products for resale and field-level commercialization across local markets.

Agricultural value-chain partners

Use or distribute technologies that support sustainable and climate-resilient production.

Strategy

Bioceres focuses on expanding its biotech platform across seeds, microbial inputs, and next-generation crop nutrition and protection. The company is also emphasizing organizational simplification, working-capital discipline, and capital allocation to support commercialization and cash generation.

Commercialize proprietary ag-biotech platformsMedium term

Patented technologies can support differentiation and pricing power in input-heavy markets.

Broaden the product portfolioMedium term

A wider product set increases cross-selling opportunities and reduces reliance on any single solution.

Improve operating efficiency and capital allocationShort term

Ag-input businesses require disciplined inventory, receivables, and cash management to support growth.

Geography

Bioceres is headquartered in Argentina and operates with a strong Latin American footprint, while also serving markets beyond its home base. Its commercial exposure is shaped by agricultural cycles, local currency conditions, and country-specific adoption of agri-biotech products. The company’s operational base in Rosario, Argentina, makes South America especially important to its supply chain and commercialization model.

Risks

The business is exposed to agricultural demand cycles, weather variability, and adoption risk around new crop technologies. As a multinational ag-input company, it also faces currency, financing, and execution risk across operating subsidiaries, along with regulatory and product-approval risk common to seed and microbial technologies.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Agricultural cycle and weather dependence1Currency and financing exposure2Technology adoption risk3
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Agricultural cycle and weather dependenceImpact: HighLikelihood: High

    Demand for seeds and crop inputs varies with planting decisions, rainfall, and crop conditions.

    Exposure: Global agricultural markets

  2. Currency and financing exposureImpact: HighLikelihood: High

    Cross-border operations and local operating subsidiaries create FX and working-capital sensitivity.

    Exposure: Argentina and other operating markets

  3. Technology adoption riskImpact: HighLikelihood: Medium

    New biotech and microbial products must gain farmer trust and field performance validation.

    Exposure: Seed traits and microbial inputs

Accounting

Judgemental items
Adjusted EBITDA reconciliation

Non-GAAP results exclude stock compensation, D&A, and transaction items, affecting comparability.

Impact: Impacts how investors assess operating performance

Transaction expenses and contingencies

One-time charges can materially change quarterly earnings presentation.

Impact: Affects period-to-period profit comparability

Financing costs and interest expense

Higher debt-related costs flow through reported profit and can overshadow operating performance.

Impact: Affects net income and earnings quality

Publicly listed companies with a comparable business focus.

Last updated: 28/09/2026